Cargando…

Can Lipoprotein-associated Phospholipase A2 be Used as a Predictor of Long-term Outcome in Patients with Acute Coronary Syndrome?

Studies indicate that elevated plasma concentrations of lipoprotein-associated phospholipase A2 (Lp-PLA2) is associated with increased risk of cardiovascular disease. Lp-PLA2 seems to play a crucial role in the formation of plaques and acute inflammation, and plasma Lp-PLA2 could therefore potential...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holst-Albrechtsen, Sine, Kjaergaard, Maria, Huynh, Anh-Nhi Thi, Kragh Sorensen, Johanne, Hosbond, Susanne, Nybo, Mads
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941095/ https://www.ncbi.nlm.nih.gov/pubmed/24313641 http://dx.doi.org/10.2174/1573403X09666131202143349

Ejemplares similares

Lipoprotein-associated phospholipase A2 and oxidized low-density lipoprotein in young patients with acute coronary syndrome in China
por: Huang, Yuli, et al.
Publicado: (2017)

Association of Lipoprotein-Associated Phospholipase A(2) with Characteristics of Vulnerable Coronary Atherosclerotic Plaques
por: Liu, Yu-Sheng, et al.
Publicado: (2011)

The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease
por: Zhang, Hao, et al.
Publicado: (2020)

Association of Lipoprotein-associated Phospholipase A2 with Coronary Calcification among American and Japanese Men
por: El-Saed, Aiman, et al.
Publicado: (2007)

Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow
por: Ding, Yao-dong, et al.
Publicado: (2020)

Lipoprotein‐associated phospholipase A2: The story continues
por: Huang, Fubao, et al.
Publicado: (2019)

Study on the correlation between the concentration of plasma lipoprotein-associated phospholipase A2 and coronary heart disease
por: Cen, Jin-Ming, et al.
Publicado: (2015)

The Relationship Between Lipoprotein-Associated Phospholipase-A2 and Coronary Artery Aneurysm in Children With Kawasaki Disease
por: Cheng, Zhenli, et al.
Publicado: (2022)

An association study between genetic polymorphisms related to lipoprotein-associated phospholipase A(2) and coronary heart disease
por: XU, LIMIN, et al.
Publicado: (2013)

Lipoprotein-Associated Phospholipase A(2) Is Related to Plaque Stability and Is a Potential Biomarker for Acute Coronary Syndrome
por: Chung, Hyemoon, et al.
Publicado: (2014)

Change in lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndrome
por: Li, Jingwei, et al.
Publicado: (2018)

Diabetes status modifies the long-term effect of lipoprotein-associated phospholipase A2 on major coronary events
por: Siddiqui, Moneeza K., et al.
Publicado: (2021)

Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease
por: Doody, Rachelle S., et al.
Publicado: (2015)

Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus
por: Poulsen, Mikael K, et al.
Publicado: (2011)

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies
Publicado: (2010)

Alteration in lipoprotein-associated phospholipase A2 levels during acute coronary syndrome and its relationship to standard biomarkers
por: Ostadal, Petr, et al.
Publicado: (2012)

Lipoprotein-Associated Phospholipase A2 Activity Predicts Cardiovascular Events in High Risk Coronary Artery Disease Patients
por: Maiolino, Giuseppe, et al.
Publicado: (2012)

Relationship between Plasma Lipoprotein-Associated Phospholipase A2 Concentrations and Apolipoprotein in Stable Coronary Artery Disease Patients
por: Ling, Yang, et al.
Publicado: (2020)

Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease
por: Mourouzis, Konstantinos, et al.
Publicado: (2021)

The Prognostic Value of Lipoprotein-Associated Phospholipase A(2) in the Long-Term Care of Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Yang, Lijiao, et al.
Publicado: (2017)

Can admission lipoprotein-associated phospholipase A2 predict the symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage?
por: Ding, Chen-Yu, et al.
Publicado: (2020)

Comparison of Lipoprotein-Associated Phospholipase A2 and High Sensitive C-Reactive Protein as Determinants of Metabolic Syndrome in Subjects without Coronary Heart Disease: In Search of the Best Predictor
por: Acevedo, Mónica, et al.
Publicado: (2015)

Racial variation in lipoprotein-associated phospholipase A(2 )in older adults
por: Lee, Keane K, et al.
Publicado: (2011)

Secreted phospholipase A(2), lipoprotein hydrolysis, and atherosclerosis: integration with lipidomics
por: Yamamoto, Kei, et al.
Publicado: (2011)

Elevated Lipoprotein-Associated Phospholipase A2 Is Associated With Intracranial Atherosclerosis
por: Wang, Yuan, et al.
Publicado: (2022)

Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome: a Danish population-based cohort study
por: Kristensen, Marie Skov, et al.
Publicado: (2020)

Lipoprotein-Associated Phospholipase A(2) Activity and Incident Coronary Heart Disease Among Men and Women With Type 2 Diabetes
por: Hatoum, Ida J., et al.
Publicado: (2010)

Lipoprotein-associated phospholipase-A(2) activity and its diagnostic potential in patients with acute coronary syndrome and acute ischemic stroke
por: Kocak, Sedat, et al.
Publicado: (2016)

Lipoprotein-associated phospholipase A2, myeloperoxidase and vascular endothelial growth factor - predictors of high vascular risk in respiratory bacterial infections
por: Seri, A, et al.
Publicado: (2016)

Lipoprotein-Associated Phospholipase A(2), Vascular Inflammation and Cardiovascular Risk Prediction
por: Sudhir, Krishnankutty
Publicado: (2006)

Is lipoprotein-associated phospholipase A(2) correlated with cardiovascular risk in European women?
por: Hirschler, V.
Publicado: (2013)

Interleukin-6 and lipoprotein-associated phospholipase A2 are associated with functional trajectories
por: Dhamoon, Mandip S., et al.
Publicado: (2019)

The correlation between lipoprotein associated phospholipase A(2) and central overweight status
por: Chen, Yi-Hsuan, et al.
Publicado: (2021)

Lipoprotein-associated phospholipase A(2): A paradigm for allosteric regulation by membranes
por: Mouchlis, Varnavas D., et al.
Publicado: (2022)

Lipoprotein-Associated Phospholipase A2 Activity as Potential Biomarker of Vascular Dementia
por: Zuliani, Giovanni, et al.
Publicado: (2023)

The diagnostic value of lipoprotein-associated phospholipase A2 in early diabetic nephropathy
por: Zhai, Yan, et al.
Publicado: (2023)

Elevated lipoprotein(a) as a predictor for coronary events in older men
por: Bartoli-Leonard, Francesca, et al.
Publicado: (2022)

Elevated lipoprotein(a) and lipoprotein-associated phospholipase A(2) are associated with unfavorable functional outcomes in patients with ischemic stroke
por: Jiang, Xue, et al.
Publicado: (2021)

Effects of canola or olive oil on plasma lipids, lipoprotein-associated phospholipase A(2) and inflammatory cytokines in patients referred for coronary angiography
por: Khandouzi, Nafiseh, et al.
Publicado: (2020)

Non-specific phospholipase C (NPC): an emerging class of phospholipase C in plant growth and development
por: Nakamura, Yuki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7bj86kar0gh599l5bcjp08vr8q